United States:
‘Clawbacks' Declawed: Act 146 Limits Retroactive Denials
06 February 2017
Fox Rothschild LLP
To print this article, all you need is to be registered or login on Mondaq.com.
William H. Maruca authored the Allegheny County Medical
Society Bulletin article, "'Clawbacks' Declawed:
Act 146 Limits Retroactive Denials." Download a PDF of this article.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
